Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opicapone vs Levodopa for Early Wearing-Off in Parkinson's Disease
NCT04990284Phase 4Completed
- Sponsor
- BIAL
- Start
- Nov 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 4 trial of opicapone in Parkinson's disease (PD), sponsored by BIAL. Started Nov 2021; status: completed.
02
Drugs
opicapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04990284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04990284.